Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Anemia during adjuvant chemotherapy predicts poor survival
May 26th, 2005
Anemia during adjuvant chemotherapy predicts poor survival in women with primary breast cancer, researchers report. "Tumor anemia is a common symptom in cancer patients, particularly in those receiving chemotherapy. The aim of the current study was to analyze the impact of hemoglobin [Hb] levels on the prognosis of patients with primary breast cancer receiving adjuvant chemotherapy," said C. Peters-Engl and colleagues, Krankenhaus Lainz, Vienna, Austria. Estimated, median, 5-year, overall survival rate for 129 patients was 76.6%. "Mean Hb prior to primary surgery was 13.8 g/dl (SD 1.09), prechemotherapy Hb 12.8 g/dl (SD 1.2), and...
Source: Women's Health Weekly (2005-05-26)
|
